Cetuximab biomarker study
Not Applicable
- Conditions
- Recurrent or metastatic colorectal cancer
- Registration Number
- JPRN-UMIN000002165
- Lead Sponsor
- Kobe University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1.active synchronous malignancy 2.pregnancy 3.severe psychological disease 4.systemic steroid administration 5.HBV carrier 6.uncontrolled diabetes 7.severe fluid collection 8.bowel obstruction 9.cardiovasucular disease within 3months 10.severe comorbidity 11.active infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method correlatopn between biomarkers and efficacy and side effects of cetuximab
- Secondary Outcome Measures
Name Time Method